Mindray has entered the transient elastography market with the launch of the Hepatus 6 Diagnostic Ultrasound System. The Hepatus 6 Ultrasound combines transient elastography and diagnostic ultrasound in one device, making it ideally suited for non-invasive detection, diagnosis and evaluation of liver disease.
“Mindray has continued to show its dedication and perseverance for industry-leading technology that pushes the boundaries of health care innovation. With the strategic entrance into the transient elastography imaging market, Mindray is committed to making an impact and addressing the growing prevalence of chronic liver disease and rising public health care concern,” a press release states.
“Mindray’s trailblazing technology in liver care brings clinicians a complete solution for non-invasive liver disease management using transient elastography. The Hepatus 6 System features a new suite of quantitative tools for evaluating liver disease providing clinicians with an easy-to-use and reliable solution for diagnosing liver fibrosis and liver steatosis,” the release adds.
